July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
Proteomic analysis of Oxygen Induced Retinopathy Model using SWATH -MS proteomics reveals novel potential therapeutic target molecules
Author Affiliations & Notes
  • Hannele Uusitalo-Jarvinen
    Eye Centre, Tampere University Hospital, Tampere, Finland
    Faculty of Medicine & Life Sciences, University of Tampere, Tampere, Finland
  • Maria Vähätupa
    Faculty of Medicine & Life Sciences, University of Tampere, Tampere, Finland
  • Janika Nättinen
    Faculty of Medicine & Life Sciences, University of Tampere, Tampere, Finland
  • Antti Jylha
    Faculty of Medicine & Life Sciences, University of Tampere, Tampere, Finland
  • Marko Kataja
    Eye Centre, Tampere University Hospital, Tampere, Finland
  • Ulla Aapola
    Faculty of Medicine & Life Sciences, University of Tampere, Tampere, Finland
  • Tero Jarvinen
    Faculty of Medicine & Life Sciences, University of Tampere, Tampere, Finland
    Orthopaedics, Tampere University Hospital, Tampere, Finland
  • Hannu M T Uusitalo
    Faculty of Medicine & Life Sciences, University of Tampere, Tampere, Finland
    Eye Centre, Tampere University Hospital, Tampere, Finland
  • Footnotes
    Commercial Relationships   Hannele Uusitalo-Jarvinen, None; Maria Vähätupa, None; Janika Nättinen, None; Antti Jylha, None; Marko Kataja, None; Ulla Aapola, None; Tero Jarvinen, None; Hannu Uusitalo, None
  • Footnotes
    Support  Diabetes research foundation, Eye Foundation
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 5477. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Hannele Uusitalo-Jarvinen, Maria Vähätupa, Janika Nättinen, Antti Jylha, Marko Kataja, Ulla Aapola, Tero Jarvinen, Hannu M T Uusitalo; Proteomic analysis of Oxygen Induced Retinopathy Model using SWATH -MS proteomics reveals novel potential therapeutic target molecules. Invest. Ophthalmol. Vis. Sci. 2018;59(9):5477.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Mouse oxygen-induced retinopathy (OIR) model is an animal model sharing many hallmarks with human neovascular eye diseases. We performed characterization of proteins involved in OIR pathogenesis by a recently developed technique, sequential window acquisition of all theoretical mass spectra (SWATH-MS) proteomics.

Methods : Retinas from control and OIR retinas were harvested at P13 (n=5/5 retinas), P17 (n=9/6 retinas) and P42 (n=6/7 retinas) and subjected to SWATH-MS and bioinformatics data analysis, including Ingenuity pathway analysis (IPA). To validate the results obtained from SWATH-MS, mouse retinas were subjected to immunohistochemistry for chosen proteins. In addition, neovascular membranes from human proliferative diabetic retinopathy (PDR) and retinal vein occlusion (RVO) were used to study the clinical relevance of one of the proteins quantified with proteomics.

Results : We were able to relatively quantify almost 3 000 unique proteins and their expression differences between normal and OIR retinas. When comparing OIR retinas to controls, there were 17 differently expressed proteins at P13 and 22 at P17 (adjusted p<0.05). Most upregulated proteins at P13 OIR (by fold change (FC)) were crystallins (log2 FC 2.67-4.32, non-adjusted p<0.05) IPA analysis connected the differing proteins at P13 OIR to phototransduction pathway (p=4.95e-10), protein kinase A signaling (p=2.29e-04) and glutamine biosynthesis I (p=8.05e-04). IPA analysis revealed increased angiogenesis (P=2.53e-04, activation z-score ≥ 2) at P17 OIR, due to upregulation of 7 proteins, such as Filamin-A (log2 FC = 0.84, p=0.03) and Myosin-9 (log2 FC = 0.92, p=0.05). Majority of the changes in protein expression return to normal at P42, but there is evidence to suggest that proteins involved in neurotransmission remain at reduced level.

Conclusions : We have carried out the most extensive proteomic profiling of OIR to date and the results reveal new potential targets to address pathological angiogenesis in retinal diseases. Our analysis reveals novel molecular networks that could contribute to the pathogenesis of neovascular retinal diseases.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×